{"id":194441,"date":"2024-08-12T23:22:32","date_gmt":"2024-08-13T04:22:32","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/08\/metformin-and-the-tame-trial-a-conversation-with-nir-barzilai-and-brad-stanfield"},"modified":"2024-08-12T23:22:32","modified_gmt":"2024-08-13T04:22:32","slug":"metformin-and-the-tame-trial-a-conversation-with-nir-barzilai-and-brad-stanfield","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/08\/metformin-and-the-tame-trial-a-conversation-with-nir-barzilai-and-brad-stanfield","title":{"rendered":"Metformin and the TAME trial: a conversation with Nir Barzilai and Brad Stanfield"},"content":{"rendered":"<p><\/p>\n<p><iframe loading=\"lazy\" title=\"Metformin and the TAME trial: a conversation with Nir Barzilai and Brad Stanfield\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/kGF1lNZ8nvg?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p>In this interview, hosted by Nicol\u00e1s Cher\u00f1avsky, Nir Barzilai and Brad Stanfield discuss metformin, whether or not to use it in non-diabetic patients to slow aging, and the TAME trial.<\/p>\n<p>Nir Barzilai is president of the Academy of Health and Lifespan Research (<a href=\"https:\/\/www.ahlresearch.org\/),\">https:\/\/www.ahlresearch.org\/),<\/a> and Brad Stanfield is a primary care physician in Auckland (New Zealand) and runs a YouTube channel (\/ <a href=\"https:\/\/twitter.com\/drbradstanfield\">@drbradstanfield<\/a>) with around 250,000 subscribers to explore the latest research and preventive care guidelines.<\/p>\n<p>Host: Nicol\u00e1s Cher\u00f1avsky.<br \/> Production: Nicol\u00e1s Cher\u00f1avsky and Nina Torres Zanvettor.<br \/> Editing: Nina Torres Zanvettor.<br \/> Revision and subtitling: Nicol\u00e1s Cher\u00f1avsky.<\/p>\n<p>============================================================<br \/> Notes:<br \/> TAME trial website: <a href=\"https:\/\/www.afar.org\/tame-trial\">https:\/\/www.afar.org\/tame-trial<\/a>.<br \/> Diabetes Prevention Program Outcomes Study (DPPOS): <a href=\"https:\/\/repository.niddk.nih.gov\/stud\">https:\/\/repository.niddk.nih.gov\/stud<\/a>\u2026<br \/> UK metformin vs sulfonylurea trial on type 2 diabetics: <a href=\"https:\/\/www.cmajopen.ca\/content\/2\/3\/E162\">https:\/\/www.cmajopen.ca\/content\/2\/3\/E162<\/a><br \/> The New England Journal of Medicine paper on metformin treatment in Covid-19 patients: <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\">https:\/\/www.nejm.org\/doi\/full\/10.1056<\/a>\u2026<br \/> Lancet paper on metformin treatment in Covid-19 patients: <a href=\"https:\/\/www.thelancet.com\/journals\/la\">https:\/\/www.thelancet.com\/journals\/la<\/a>\u2026<br \/> Andre Scott\u2019s paper on the cost-effectiveness of treating aging: <a href=\"https:\/\/www.nature.com\/articles\/s4358\">https:\/\/www.nature.com\/articles\/s4358<\/a>\u2026<br \/> Medical guidelines database mentioned by Brad Stanfield: <a href=\"https:\/\/uptodate.com\">https:\/\/uptodate.com<\/a>.<br \/> ============================================================<\/p>\n<p>Heales website (Healthy Life Extension Society): <a href=\"https:\/\/heales.org\/\">https:\/\/heales.org\/<\/a><\/p>\n<p>Contact e-mail: <a href=\"mailto:info@heales.org.\">info@heales.org.<\/a><\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2024\/08\/metformin-and-the-tame-trial-a-conversation-with-nir-barzilai-and-brad-stanfield\">Continue reading \u201cMetformin and the TAME trial: a conversation with Nir Barzilai and Brad Stanfield\u201d | &gt;<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In this interview, hosted by Nicol\u00e1s Cher\u00f1avsky, Nir Barzilai and Brad Stanfield discuss metformin, whether or not to use it in non-diabetic patients to slow aging, and the TAME trial. Nir Barzilai is president of the Academy of Health and Lifespan Research (https:\/\/www.ahlresearch.org\/), and Brad Stanfield is a primary care physician in Auckland (New Zealand) [\u2026]<\/p>\n","protected":false},"author":568,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495],"tags":[],"class_list":["post-194441","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/194441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/568"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=194441"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/194441\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=194441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=194441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=194441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}